Literature DB >> 19952402

[Association of genetic polymorphism in phenylethanolamine-N-methyl transferase with essential hypertension in Changsha Han people].

An Chen1, Xiaoping Chen, Ruizheng Shi, Yijie Guo, Lujia Chen, Mingxuan Xie, Tianlun Yang, Guogang Zhang.   

Abstract

OBJECTIVE: To investigate the association of phenylethanolamine-N-methyl transferase (PNMT) G-390A genetic polymorphism with risk of essential hypertension (EH) in Changsha Han people.
METHODS: A case-control association study was performed in 400 patients with essential hypertension (EH) and 388 normotensive subjects. PNMT G-390A was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-FRLP).
RESULTS: The genotype frequencies for the -390 GG, GA, and AA were 39.3%,50.0%, and 10.8%, respectively in EH patients, and were 43.6%,45.6%, and 10.8%, in normal subjects. No significant difference in either genotypic frequency (P=0.433) or allele frequency (P=0.378) of PNMT G-390A between EH patients and normals was observed. When by gender, there was significant difference in genotypic frequency (P<0.05) and allele frequency (P=0.046) of G-390A polymorphism between EH patients and normals in the male, but not in the female (P>0.05).
CONCLUSION: PNMT G-390A polymorphism is possibly associated with EH risk in male Chinese Han population in Changsha.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952402

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

1.  Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension.

Authors:  Ryan S Friese; Geert W Schmid-Schönbein; Daniel T O'Connor
Journal:  Blood Press       Date:  2011-03-23       Impact factor: 2.835

2.  Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.

Authors:  Li-Na Zhang; Pan-Pan Liu; Lingyan Wang; Fang Yuan; Leiting Xu; Yanfei Xin; Li-Juan Fei; Qi-Long Zhong; Yi Huang; Limin Xu; Ling-Mei Hao; Xu-Jun Qiu; Yanping Le; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.